Biologic choice matters in PsA prevention
Biologic choice matters in PsA prevention
About this item
Full title
Biologic choice matters in PsA prevention
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Nature reviews. Rheumatology, 2023-05, Vol.19 (5), p.256-256
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
In a large cohort of patients with psoriasis, treatment with biologic DMARDs targeting the IL-23 pathway was associated with a reduced risk of developing inflammatory arthritis as compared with anti-TNF treatment.
Alternative Titles
Full title
Biologic choice matters in PsA prevention
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2791374905
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2791374905
Other Identifiers
ISSN
1759-4790
E-ISSN
1759-4804
DOI
10.1038/s41584-023-00955-z
